Highly expressed miR-375 is not an intracellular 2 oncogene in Merkel cell polyomavirus-associated 3 Merkel cell carcinoma 4

miR-375 is a highly abundant miRNA in Merkel cell carcinoma (MCC), in other cancers it 16 acts either as a tumor suppressor or oncogene. While free-circulating miR-375 serves as surrogate 17 marker for tumor burden in patients with advanced MCC, its function within MCC cells has not 18 been established. Nearly complete miR-375 knockdown in MCC cell lines was achieved using 19 antagomiRs via nucleofection. Neither cell viability, growth characteristics nor morphology were 20 altered by this knockdown. miR-375 target genes and related signaling pathways were determined 21 using ENCORI revealing Hippo signaling and EMT-related genes likely to be regulated. Thus, their 22 expression was analyzed by multiplexed qRT-PCR after miR-375 knockdown demonstrating only a 23 limited change in expression. In summary, highly effective miR-375 knockdown in classical MCC 24 cell lines did neither significantly change cell viability, morphology, nor oncogenic signaling 25 pathways. These observations render miR-375 an unlikely intracellular oncogene in MCC cells, thus 26 suggesting to address likely functions of miR-375 for intercellular communication of MCC. 27

[1]  V. Sondak,et al.  The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy , 2019, Clinical Cancer Research.

[2]  C. Larsson,et al.  Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes , 2019, International journal of cancer.

[3]  J. Utikal,et al.  Characterization of six Merkel cell polyomavirus‐positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration , 2019, International journal of cancer.

[4]  Olga Tanaseichuk,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[5]  Li Sun,et al.  Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer , 2019, Journal of Ovarian Research.

[6]  Yizheng Wu,et al.  CircFAT1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells , 2018, Molecular Cancer.

[7]  I. MacRae,et al.  Regulation of microRNA function in animals , 2018, Nature Reviews Molecular Cell Biology.

[8]  G. Aquino-Jarquin Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research. , 2017, Cancer research.

[9]  Chung-I Wu,et al.  Redundant and incoherent regulations of multiple phenotypes suggest microRNAs’ role in stability control , 2017, Genome research.

[10]  Hong Liu,et al.  The long noncoding RNA, TINCR, functions as a competing endogenous RNA to regulate PDK1 expression by sponging miR-375 in gastric cancer , 2017, OncoTargets and therapy.

[11]  S. Haferkamp,et al.  RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells , 2016, Oncotarget.

[12]  H. Feilotter,et al.  Roles for miR-375 in Neuroendocrine Differentiation and Tumor Suppression via Notch Pathway Suppression in Merkel Cell Carcinoma. , 2016, The American journal of pathology.

[13]  Yong Peng,et al.  The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.

[14]  Gisela Mir Arnau,et al.  UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas. , 2015, Cancer research.

[15]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[16]  Hui Zhou,et al.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..

[17]  M. Raffeld,et al.  Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma. , 2013, Experimental and molecular pathology.

[18]  H. Feilotter,et al.  Multicolor microRNA FISH effectively differentiates tumor types. , 2013, The Journal of clinical investigation.

[19]  B. Cieply,et al.  Mechanisms that link the oncogenic epithelial–mesenchymal transition to suppression of anoikis , 2013, Journal of Cell Science.

[20]  Xing-Xing He,et al.  MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo , 2012, Oncogene.

[21]  A. Dömling,et al.  Survivin Is a Therapeutic Target in Merkel Cell Carcinoma , 2012, Science Translational Medicine.

[22]  J. Cen,et al.  MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro. , 2012, Oncology research.

[23]  P. Gao,et al.  Expression levels of microRNA-375 in colorectal carcinoma. , 2012, Molecular medicine reports.

[24]  Stefan L Ameres,et al.  Long-term, efficient inhibition of microRNA function in mice using rAAV vectors , 2012, Nature Methods.

[25]  Arndt Hartmann,et al.  Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma , 2011, Molecular Cancer Research.

[26]  Jianmin Si,et al.  MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2 , 2010, Cell Research.

[27]  M. Seto,et al.  MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. , 2010, Cancer research.

[28]  M. Stoffel,et al.  Specificity, duplex degradation and subcellular localization of antagomirs , 2007, Nucleic acids research.

[29]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[30]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  N. Rajewsky,et al.  A pancreatic islet-specific microRNA regulates insulin secretion , 2004, Nature.

[32]  I. Varela,et al.  Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas. , 2017, The Journal of investigative dermatology.

[33]  S. Knuutila,et al.  Hotspot mutations in polyomavirus positive and negative Merkel cell carcinomas. , 2016, Cancer genetics.

[34]  Tao Wang,et al.  Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. , 2015, European urology.

[35]  Luigi Naldini,et al.  Stable knockdown of microRNA in vivo by lentiviral vectors , 2009, Nature Methods.